|
Volumn 77, Issue 918, 2004, Pages 519-520
|
Radical radiotherapy for early laryngeal cancer in a patient with human immunodeficiency virus: No evidence of increased toxicity
a b c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
CD4 ANTIGEN;
EFAVIRENZ;
IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;
LAMIVUDINE PLUS ZIDOVUDINE;
SALBUTAMOL;
ADULT;
ARTICLE;
ASTHMA;
BODY WEIGHT DISORDER;
CASE REPORT;
EARLY CANCER;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE STATUS;
INDIVIDUALIZATION;
LARYNGEAL BIOPSY;
LARYNX CANCER;
LARYNX DISORDER;
MALE;
MICROLARYNGOSCOPY;
MORBIDITY;
SQUAMOUS CELL CARCINOMA;
TREATMENT INDICATION;
TUMOR DIFFERENTIATION;
ERYTHEMA;
LARYNX TUMOR;
RADIATION EXPOSURE;
RADIATION INJURY;
SKIN;
VOCAL CORD;
ADULT;
CARCINOMA, SQUAMOUS CELL;
ERYTHEMA;
HIV INFECTIONS;
HUMANS;
LARYNGEAL NEOPLASMS;
MALE;
RADIATION INJURIES;
SKIN;
VOCAL CORDS;
|
EID: 3042548806
PISSN: 00071285
EISSN: None
Source Type: Journal
DOI: 10.1259/bjr/51408454 Document Type: Article |
Times cited : (7)
|
References (9)
|